Abbott introduces new DRG Invisible Trial System for chronic pain management

Abbott has announced the launch of the new DRG Invisible Trial System, approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe.

People suffering from complex chronic pain conditions can now use the DRG Invisible Trial System to try Abbott’s dorsal root ganglion (DRG) stimulation—it’s clinically proven, non-opioid treatment option for targeted chronic pain management.

Patients who are relieved with DRG therapy can then have Abbott’s Proclaim DRG system implanted, it empowers them to manage their pain with familiar Apple consumer technology.

Know More

👇🏻 Please Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Your Health in Your Hand

Hypertension coupled with stress and sleeplessness increases brain attack risks

  According to health experts, High blood pressure along with stress and lack of sleep increases heart attack and brain...

Mental Health Issue – A Silent Crisis

  According to social trends, men are treated as stronger sex than women. More importance is given to physical fitness...

Slow Living – A Key for stress free life

  Modern Society depicts a never ending to-do list, constant multitasking, being busy 24x7. Busyness is thought to be a...

50+ Women are more prone to Chronic Kidney Disease

  Type-2 Diabetes was the main factor for more women experiencing kidney failure.  Usually brought out by Obesity, diabetes is...

India set to generate global fund for AIDS, TB & Malaria program

India is ready to set funds for AIDS, TB and malaria program and sustain health systems across the world. With...